K
Kimberly Steinberg
Researcher at University of Rochester
Publications - 4
Citations - 2136
Kimberly Steinberg is an academic researcher from University of Rochester. The author has contributed to research in topics: Huntington's disease & Trinucleotide repeat expansion. The author has an hindex of 4, co-authored 4 publications receiving 1930 citations. Previous affiliations of Kimberly Steinberg include University of Rochester Medical Center.
Papers
More filters
Journal ArticleDOI
Unified huntington’s disease rating scale: Reliability and consistency
Karl Kieburtz,John B. Penney,Peter Corno,Neal G. Ranen,Ira Shoulson,Andrew Feigin,Davi Abwender,J. Timothy Greenarnyre,Donald S. Higgins,Frederick J. Marshall,Joshua L. Goldstein,Kimberly Steinberg,Charles Shih,Irene H. Richard,Charlyne Hickey,Carol Zimmerman,Constance Orme,Kathy Claude,David Oakes,Daniel S. Sax,Anthony Kim,Steven M. Hersch,Randi Jones,Alexander P. Auchus,David B. Olsen,Cheryl Bissey-Black,Allen Rubin,Rose Schwartz,Richard Dubinsky,William Mallonee,Carolyn Gray,Nan Godfrey,Greg Suter,Kathleen M. Shannon,Glenn T. Stebbins,Jean A. Jaglin,Karen Marder,Stuart Taylor,Elan D. Louis,Carol Moskowitz,Deborah Zeck Thorne,Naomi Zubin,Nancy S. Wexler,Michael R. Swenson,Jane S. Paulsen,Neal R. Swerdlow,Roger L. Albin,Christine Wernette,Francis O. Walker,Vicki Hunt +49 more
TL;DR: The limited longitudinal database indicates that the UHDRS may be useful for tracking changes in the clinical features of HD over time and there was an excellent degree of interrater reliability for the motor scores.
Journal ArticleDOI
Trinucleotide repeat length and progression of illness in Huntington's disease.
Karl Kieburtz,Marcy E. MacDonald,C Shih,Andrew Feigin,Kimberly Steinberg,K. Bordwell,Carol Zimmerman,Jayalakshmi Srinidhi,Jenny Sotack,J. F. Gusella +9 more
TL;DR: It is suggested that the CAG repeat length may influence or trigger the onset of HD, but other genetic, neurobiological, or environmental factors contribute to the progression of illness and the underlying pace of neuronal degeneration.
Journal ArticleDOI
Functional decline in Huntington's disease
Andrew Feigin,Karl Kieburtz,K. Bordwell,Peter Como,Kimberly Steinberg,Jenny Sotack,Carol Zimmerman,Charlyne Hickey,Constance Orme,Ira Shoulson +9 more
TL;DR: There was no correlation between rate of functional decline and age at onset of HD, body weight, gender of affected parent, or history of neuroleptic use.
Journal ArticleDOI
Assessment of coenzyme Q10 tolerability in Huntington's disease
Andrew Feigin,Karl Kieburtz,Peter Como,Charlyne Hickey,Kathy Claude,David A. Abwender,Carol Zimmerman,Kimberly Steinberg,Ira Shoulson +8 more
TL;DR: The good tolerability of CoQ suggests that it is a good candidate for evaluation in liong–term clinical trials designed to slow the progression of HD.